Alto Neuroscience Has Initiated Phase 2 Study Of ALTO-203 In Major Depressive Disorder; Alto Expects To Report Topline Data From This Study In 1H Of 2025
Alto Neuroscience Has Initiated Phase 2 Study Of ALTO-203 In Major Depressive Disorder; Alto Expects To Report Topline Data From This Study In 1H Of 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.